LATS1 and cancer: Decreased level of LATS1 immunoreactivity in ccRCC cells, as observed in the present study, corresponds to the analysis of LATS1 gene expression on another set of ccRCC patients where we observed strong association between decreased LATS1 mRNA and protein contents in cancer tissue lysates [13].